Variant report

Variant	esv3425128
Chromosome Location	chr4:818377-821325
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:819446-819522	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr4:819894-819984	K562	blood:	n/a	n/a
3	BHLHE40	chr4:819415-819463	K562	blood:	n/a	n/a
4	CCNT2	chr4:819353-819529	K562	blood:	n/a	n/a
5	CCNT2	chr4:819783-819973	K562	blood:	n/a	chr4:819957-819966
6	CHD2	chr4:819901-820071	Hela-S3	cervix:	n/a	chr4:819955-819965
7	CHD2	chr4:820804-820813	H1-hESC	embryonic stem cell:	n/a	n/a
8	CREB1	chr4:819832-820160	HepG2	liver:	n/a	n/a
9	CREB1	chr4:819757-820087	K562	blood:	n/a	n/a
10	CREB1	chr4:819784-820055	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTBP2	chr4:820592-820908	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTBP2	chr4:818452-819542	H1-hESC	embryonic stem cell:	n/a	n/a
13	CTCF	chr4:818280-818430	HCM	heart:	n/a	n/a
14	CTCF	chr4:818300-818550	GM06990	blood:	n/a	n/a
15	CTCF	chr4:818314-818379	GM19240	blood:	n/a	n/a
16	CTCF	chr4:818260-818410	HCPEpiC	choroid plexus:	n/a	n/a
17	CTCF	chr4:818340-818490	HBMEC	blood vessel:	n/a	n/a
18	CTCF	chr4:818240-818390	WERI-Rb-1	eye:	n/a	n/a
19	CTCF	chr4:818282-818420	K562	blood:	n/a	n/a
20	CTCF	chr4:818640-818790	SK-N-SH_RA	brain:	n/a	chr4:818691-818701
21	CTCF	chr4:818229-818413	GM12878	blood:	n/a	n/a
22	CTCF	chr4:818260-818410	BE2_C	brain:	n/a	n/a
23	CTCF	chr4:818560-818710	WERI-Rb-1	eye:	n/a	chr4:818691-818701
24	E2F6	chr4:819278-819552	K562	blood:	n/a	n/a
25	E2F6	chr4:819787-820016	K562	blood:	n/a	chr4:819964-819973 chr4:819954-819966 chr4:819906-819916 chr4:819957-819966
26	EGR1	chr4:819705-820114	K562	blood:	n/a	chr4:819957-819967 chr4:819958-819971
27	EGR1	chr4:820240-820923	K562	blood:	n/a	chr4:820308-820321 chr4:820405-820415 chr4:820312-820322 chr4:820410-820423 chr4:820370-820380 chr4:820408-820418
28	EGR1	chr4:819305-819682	K562	blood:	n/a	n/a
29	EGR1	chr4:820198-820576	K562	blood:	n/a	chr4:820308-820321 chr4:820405-820415 chr4:820312-820322 chr4:820410-820423 chr4:820370-820380 chr4:820408-820418
30	EGR1	chr4:819310-819600	K562	blood:	n/a	n/a
31	EGR1	chr4:819713-820135	K562	blood:	n/a	chr4:819957-819967 chr4:819958-819971
32	ELF1	chr4:819255-819705	K562	blood:	n/a	chr4:819426-819439 chr4:819289-819301
33	ELF1	chr4:819276-819651	K562	blood:	n/a	chr4:819426-819439 chr4:819289-819301
34	ETS1	chr4:819339-819841	K562	blood:	n/a	n/a
35	ETS1	chr4:819850-819988	K562	blood:	n/a	chr4:819960-819971 chr4:819957-819968 chr4:819958-819969
36	FOXP2	chr4:819842-820019	PFSK-1	brain:	n/a	n/a
37	GABPA	chr4:819156-819468	H1-hESC	embryonic stem cell:	n/a	chr4:819196-819205
38	GABPA	chr4:820611-820917	H1-hESC	embryonic stem cell:	n/a	n/a
39	GABPA	chr4:818571-818791	H1-hESC	embryonic stem cell:	n/a	n/a
40	HA-E2F1	chr4:819470-820087	Hela-S3	cervix:	n/a	chr4:819964-819973 chr4:819954-819966 chr4:819906-819916 chr4:819957-819966
41	HDAC2	chr4:819304-819653	H1-hESC	embryonic stem cell:	n/a	chr4:819384-819398
42	HDAC2	chr4:819361-819539	HepG2	liver:	n/a	chr4:819384-819398
43	HDAC2	chr4:819361-819650	K562	blood:	n/a	chr4:819384-819398
44	HMGN3	chr4:819319-819552	K562	blood:	n/a	n/a
45	HMGN3	chr4:820735-820742	K562	blood:	n/a	n/a
46	IRF1	chr4:820332-820470	K562	blood:	n/a	n/a
47	JUND	chr4:820688-820835	H1-hESC	embryonic stem cell:	n/a	n/a
48	JUND	chr4:820714-820732	H1-hESC	embryonic stem cell:	n/a	n/a
49	MAFF	chr4:821149-821213	HepG2	liver:	n/a	chr4:821158-821172 chr4:821152-821170
50	MAFK	chr4:821121-821217	HepG2	liver:	n/a	chr4:821154-821170 chr4:821158-821172 chr4:821154-821169 chr4:821157-821173

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:819927-819977	NB4	blood:	n/a
2	chr4:819927-819977	NB4	blood:	n/a
3	chr4:820619-820669	GM12891	blood:	n/a
4	chr4:819227-819277	H1-hESC	embryonic stem cell:	embryo
5	chr4:820619-820669	GM12878	blood:	n/a
6	chr4:820619-820669	Jurkat	blood:	n/a
7	chr4:820756-820806	AG09319	gingival:	n/a
8	chr4:821075-821125	H1-hESC	embryonic stem cell:	embryo
9	chr4:820619-820669	SK-N-SH_RA	brain:	n/a
10	chr4:819927-819977	SKMC	muscle:	n/a
11	chr4:819927-819977	ProgFib	skin:	n/a
12	chr4:820619-820669	HCT-116	colon:	n/a
13	chr4:821075-821125	PrEC	prostate:	n/a
14	chr4:819151-819201	NHBE	bronchial:	n/a
15	chr4:820756-820806	AG09309	skin:	n/a
16	chr4:819227-819277	HL-60	blood:	n/a
17	chr4:820756-820806	BJ	skin:	n/a
18	chr4:819151-819201	U87	brain:	n/a
19	chr4:819151-819201	PFSK-1	brain:	n/a
20	chr4:819927-819977	GM12878	blood:	n/a
21	chr4:820619-820669	MCF-7	breast:	n/a
22	chr4:819227-819277	HRE	kidney:	n/a
23	chr4:820756-820806	CMK	blood:	n/a
24	chr4:820756-820806	HPAEpiC	pulmonary alveolar:	n/a
25	chr4:819927-819977	HCM	heart:	n/a
26	chr4:820619-820669	HepG2	liver:	n/a
27	chr4:819151-819201	HRCEpiC	kidney:	n/a
28	chr4:821075-821125	HRCEpiC	kidney:	n/a
29	chr4:819227-819277	NB4	blood:	n/a
30	chr4:820619-820669	HRE	kidney:	n/a
31	chr4:819927-819977	HepG2	liver:	n/a
32	chr4:819927-819977	A549	lung:	n/a
33	chr4:819227-819277	AoSMC	blood vessel:	n/a
34	chr4:819927-819977	Hela-S3	cervix:	n/a
35	chr4:819227-819277	HCPEpiC	choroid plexus:	n/a
36	chr4:820756-820806	IMR90	lung:	fetal
37	chr4:821075-821125	T-47D	breast:	n/a
38	chr4:819151-819201	GM06990	blood:	n/a
39	chr4:819151-819201	IMR90	lung:	fetal
40	chr4:819151-819201	AG04449	skin:	fetal
41	chr4:820756-820806	ovcar-3	ovarian:	n/a
42	chr4:819227-819277	ECC-1	luminal epithelium:	n/a
43	chr4:819927-819977	HEK293	kidney:	embryo
44	chr4:820619-820669	IMR90	lung:	fetal
45	chr4:819151-819201	HEEpiC	esophagus:	n/a
46	chr4:819227-819277	K562	blood:	n/a
47	chr4:820756-820806	PANC-1	pancreas:	n/a
48	chr4:819151-819201	BE2_C	brain:	n/a
49	chr4:821075-821125	HCF	heart:	n/a
50	chr4:821075-821125	HEEpiC	esophagus:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:810119..812562-chr4:817081..819359,3	MCF-7	breast:
2	chr4:773678..778564-chr4:818343..821273,5	K562	blood:
3	chr4:774284..777559-chr4:817781..820963,6	MCF-7	breast:
4	chr4:779184..781836-chr4:815756..818416,2	MCF-7	breast:
5	chr4:767045..769488-chr4:820601..823147,2	K562	blood:
6	chr4:775742..777793-chr4:821294..823838,2	MCF-7	breast:
7	chr4:820499..822225-chr4:975841..977924,2	K562	blood:
8	chr4:816506..819302-chr4:925651..929828,3	K562	blood:

Variant related genes	Relation type
CPLX1	TF binding region
CPLX1	CpG island
ENSG00000127419	chromatin interactions
ENSG00000249592	chromatin interactions
ENSG00000178950	chromatin interactions

Extended variants
information (count: 105 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:105 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs372276681	chr4:818378-818379	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs114455978	chr4:818393-818394	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs77253866	chr4:818427-818428	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs2276906	chr4:818440-818441	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs566669822	chr4:818467-818468	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs142104918	chr4:818468-818469	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs554887214	chr4:818510-818511	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs552520810	chr4:818535-818536	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs570724618	chr4:818570-818571	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs538122726	chr4:818632-818633	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs146186664	chr4:818642-818643	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs2086211	chr4:818647-818648	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs535575904	chr4:818701-818702	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs575980076	chr4:818707-818708	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs75766043	chr4:818717-818718	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs573407997	chr4:818740-818741	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs377663727	chr4:818746-818747	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs371050722	chr4:818752-818753	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs116098137	chr4:818766-818767	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs558713554	chr4:818775-818776	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs577148988	chr4:818776-818777	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs376055679	chr4:818785-818786	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs377765408	chr4:818790-818791	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs558757864	chr4:818799-818800	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs544500243	chr4:818805-818806	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs577248476	chr4:818807-818808	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs562942485	chr4:818864-818865	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs530003482	chr4:818872-818873	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs542312735	chr4:818929-818930	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs573493666	chr4:818956-818957	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs527497472	chr4:818967-818968	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs542319063	chr4:819005-819006	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs35957532	chr4:819049-819050	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs552434610	chr4:819068-819069	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs551743024	chr4:819098-819099	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs570637920	chr4:819129-819130	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs373300590	chr4:819132-819133	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs531681993	chr4:819137-819138	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs549795195	chr4:819146-819147	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs568055517	chr4:819148-819149	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs370058919	chr4:819155-819156	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs535058827	chr4:819160-819161	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs553849710	chr4:819167-819168	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs374378111	chr4:819175-819176	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs114750752	chr4:819234-819235	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs190561429	chr4:819255-819256	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs112150602	chr4:819309-819310	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs146623665	chr4:819323-819324	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs117356246	chr4:819328-819329	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs541000601	chr4:819342-819343	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Wolf-Hirschhorn syndrome	21549014	CNVD
Breast cancer	21806811	CNVD
Wolf-Hirschhorn syndrome	22283845	CNVD
Wolf-Hirschhorn syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Wolf-Hirschhorn syndrome	22470819	CNVD
Wolf-Hirschhorn syndrome	18541967	CNVD
sporadic birth defects	19047251	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Retinitis pigmentosa	18421352	CNVD
Wolf-Hirschhorn syndrome	19259404	CNVD
Bladder cancer	19242612	CNVD
Breast cancer	19242612	CNVD
Congenital anomalies of the kidney and urinary tract	19242612	CNVD
abnormal development	18461090	CNVD
Olfactory neuroblastoma	18408657	CNVD
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17142309	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:310 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:815400-819200	Bivalent Enhancer	Fetal Brain Male	brain
2	chr4:816800-818400	Bivalent Enhancer	Brain Anterior Caudate	brain
3	chr4:817200-818400	Bivalent Enhancer	Brain Germinal Matrix	brain
4	chr4:817200-818600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr4:817200-819800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
6	chr4:817200-819800	Bivalent Enhancer	Placenta	Placenta
7	chr4:817600-818600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr4:817600-818800	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr4:817600-819200	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr4:817800-818400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
11	chr4:817800-818600	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
12	chr4:817800-819000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
13	chr4:817800-819200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
14	chr4:818000-818800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
15	chr4:818000-819000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
16	chr4:818000-819200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr4:818200-818600	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
18	chr4:818200-818800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
19	chr4:818200-819200	Bivalent Enhancer	Primary T cells from cord blood	blood
20	chr4:818200-819600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
21	chr4:818200-819800	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
22	chr4:818200-822200	Weak transcription	Pancreas	Pancrea
23	chr4:818400-818600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
24	chr4:818400-818600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
25	chr4:818400-818600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
26	chr4:818400-818600	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
27	chr4:818400-818600	Bivalent Enhancer	Right Ventricle	heart
28	chr4:818400-818600	Bivalent Enhancer	Thymus	Thymus
29	chr4:818400-818800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
30	chr4:818400-818800	Bivalent Enhancer	Brain Hippocampus Middle	brain
31	chr4:818400-818800	Bivalent Enhancer	Fetal Intestine Small	intestine
32	chr4:818400-818800	Bivalent Enhancer	Fetal Stomach	stomach
33	chr4:818400-819000	Bivalent/Poised TSS	Brain Anterior Caudate	brain
34	chr4:818400-819200	Bivalent Enhancer	Fetal Thymus	thymus
35	chr4:818400-819400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
36	chr4:818400-819400	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
37	chr4:818400-819600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
38	chr4:818400-819600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
39	chr4:818400-819600	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
40	chr4:818400-820000	Bivalent Enhancer	Spleen	Spleen
41	chr4:818600-818800	Flanking Bivalent TSS/Enh	ES-WA7 Cell Line	embryonic stem cell
42	chr4:818600-818800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr4:818600-818800	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
44	chr4:818600-818800	Flanking Bivalent TSS/Enh	Right Ventricle	heart
45	chr4:818600-818800	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
46	chr4:818600-819000	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
47	chr4:818600-819000	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
48	chr4:818600-819000	Bivalent Enhancer	Fetal Intestine Large	intestine
49	chr4:818600-819200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
50	chr4:818600-819200	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links